ISPOR BR: The scenario and the main barriers of real-world studies in emerging countries

ISPOR BR: The scenario and the main barriers of real-world studies in emerging countries

The main barriers and improvements to be achieved in the scenario of real world studies in emerging countries. This is the theme of the panel discussion that will be presented by Evidências - Kantar Health at the next conference of the International Society For Pharmacoeconomics and Outcomes Research (ISPOR) Latam. This year's edition will be held in the city of São Paulo (BR), from September 15th to 17th. The annual ISPOR meeting is one of the most important channels of scientific dissemination on pharmacoeconomics and results research.

The panel Real world studies and public health policies in emerging markets: needs and challenges was proposed by Guilherme Julian, Research specialist at Evidências - Kantar Health.

The discussion will feature three oral presentations. In the first, Manny Papadimitropoulos, the scientific leader in health technology assessment at Canada's Lilly Company, will outline key barriers related to the generation of real-world data in emerging countries, as well as possible strategies for overcoming them. Next, Julian will highlight examples of real-world data generation through publicly available data sources, and finally, Alexandro Dias Porto Chiavegatto Filho, a professor at the University of São Paulo's public health faculty (USP), will demonstrate examples of real-world studies using artificial intelligence to evaluate health policies. In addition, Otávio Clark, CEO of Evidências - Kantar Health will be moderator in the presentations.

"This will be a great opportunity to discuss with people from different perspectives on the use of real-world data for health decision-making and health policies in the region," says Julian.

The full contents of this panel will be available online after the congress. Please check our website soon.

Ispor in Brazil

It will be the third time that ISPOR conference is held in Brazil, which is crucial to draw attention to the scenario of the country's health system and its contribution to scientific research in the world. “The importance of having ISPOR in Brazil is that it brings the opportunity to make a local discussion about the processes of incorporation of new technologies, both in Brazil and in Latin America”, says Otávio Clark, CEO of Evidências – Kantar Health.

Evidências - Kantar Health has an active participation in ISPOR editions. Of the 21 abstracts submitted to ISPOR Latam, all were accepted! Nineteen were accepted as posters and two as oral presentations. In addition, Evidências - Kantar Health will also host a panel about real world studies and public health policies in emerging markets: needs and challenges.

Search
Newsletter

Subscribe to our newsletter

More